Results from the IRS IV randomized trial of hyperfractionated radiation in children with rhabdomyosarcoma
Sarah S. Donaldson(Stanford University), Moody D. Wharam(Johns Hopkins University), Fran Laurie(University of Massachusetts Chan Medical School), W M Crist(University of Missouri), Jane L. Meza(Children's Oncology Group), Stephen J. Qualman(Nationwide Children's Hospital), John C. Breneman(University of Cincinnati)
International Journal of Radiation Oncology*Biology*Physics
January 1, 2000
Cited by 8
Related Papers
Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases
|JAMA Oncology|2022|557
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530
A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases
|International Journal of Radiation Oncology*Biology*Physics|2002|508
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
|Pediatric Blood & Cancer|2013|459
Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
|Journal of Clinical Oncology|2008|418